Global PD-1 and PD-L1 Inhibitors Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Country/Region, 2017, 2022 & 2028

2.2 PD-1 and PD-L1 Inhibitors Segment by Type

2.2.1 Humanized IgG1(Immunoglobulin 1)

2.2.2 Humanized IgG4(Immunoglobulin 5)

2.2.3 Cytokine

2.3 PD-1 and PD-L1 Inhibitors Sales by Type

2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2017-2022)

2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022)

2.4 PD-1 and PD-L1 Inhibitors Segment by Application

2.4.1 Oral

2.4.2 Subcutaneous Injection

2.5 PD-1 and PD-L1 Inhibitors Sales by Application

2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2017-2022)

2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2017-2022)

2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022)

3 Global PD-1 and PD-L1 Inhibitors by Company

3.1 Global PD-1 and PD-L1 Inhibitors Breakdown Data by Company

3.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Company (2020-2022)

3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)

3.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Company (2020-2022)

3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022)

3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)

3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company

3.4 Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution

3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for PD-1 and PD-L1 Inhibitors by Geographic Region

4.1 World Historic PD-1 and PD-L1 Inhibitors Market Size by Geographic Region (2017-2022)

4.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Geographic Region (2017-2022)

4.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Geographic Region

4.2 World Historic PD-1 and PD-L1 Inhibitors Market Size by Country/Region (2017-2022)

4.2.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Country/Region (2017-2022)

4.2.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Country/Region

4.3 Americas PD-1 and PD-L1 Inhibitors Sales Growth

4.4 APAC PD-1 and PD-L1 Inhibitors Sales Growth

4.5 Europe PD-1 and PD-L1 Inhibitors Sales Growth

4.6 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth

5 Americas

5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country

5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)

5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)

5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type

5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region

6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022)

6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022)

6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type

6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe PD-1 and PD-L1 Inhibitors by Country

7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)

7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)

7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type

7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country

8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)

8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)

8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type

8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors

10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors

10.4 Industry Chain Structure of PD-1 and PD-L1 Inhibitors

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 PD-1 and PD-L1 Inhibitors Distributors

11.3 PD-1 and PD-L1 Inhibitors Customer

12 World Forecast Review for PD-1 and PD-L1 Inhibitors by Geographic Region

12.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region

12.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region (2023-2028)

12.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type

12.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application

13 Key Players Analysis

13.1 Merck

13.1.1 Merck Company Information

13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Offered

13.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck Main Business Overview

13.1.5 Merck Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis PD-1 and PD-L1 Inhibitors Product Offered

13.2.3 Novartis PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 Bristol-Myers Squibb

13.3.1 Bristol-Myers Squibb Company Information

13.3.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered

13.3.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bristol-Myers Squibb Main Business Overview

13.3.5 Bristol-Myers Squibb Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Product Offered

13.4.3 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Regeneron Pharmaceuticals

13.5.1 Regeneron Pharmaceuticals Company Information

13.5.2 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product Offered

13.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Regeneron Pharmaceuticals Main Business Overview

13.5.5 Regeneron Pharmaceuticals Latest Developments

13.6 Eli Lilly and Company

13.6.1 Eli Lilly and Company Company Information

13.6.2 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Product Offered

13.6.3 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Eli Lilly and Company Main Business Overview

13.6.5 Eli Lilly and Company Latest Developments

13.7 Roche Genetech

13.7.1 Roche Genetech Company Information

13.7.2 Roche Genetech PD-1 and PD-L1 Inhibitors Product Offered

13.7.3 Roche Genetech PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Roche Genetech Main Business Overview

13.7.5 Roche Genetech Latest Developments

13.8 AstraZeneca

13.8.1 AstraZeneca Company Information

13.8.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered

13.8.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AstraZeneca Main Business Overview

13.8.5 AstraZeneca Latest Developments

13.9 Jiangsu HengRui Medicine Co., Ltd.

13.9.1 Jiangsu HengRui Medicine Co., Ltd. Company Information

13.9.2 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Product Offered

13.9.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Jiangsu HengRui Medicine Co., Ltd. Main Business Overview

13.9.5 Jiangsu HengRui Medicine Co., Ltd. Latest Developments

13.10 Curis Inc.

13.10.1 Curis Inc. Company Information

13.10.2 Curis Inc. PD-1 and PD-L1 Inhibitors Product Offered

13.10.3 Curis Inc. PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Curis Inc. Main Business Overview

13.10.5 Curis Inc. Latest Developments

13.11 Aurigene

13.11.1 Aurigene Company Information

13.11.2 Aurigene PD-1 and PD-L1 Inhibitors Product Offered

13.11.3 Aurigene PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Aurigene Main Business Overview

13.11.5 Aurigene Latest Developments

14 Research Findings and Conclusion

Table 1. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Humanized IgG1(Immunoglobulin 1)

Table 4. Major Players of Humanized IgG4(Immunoglobulin 5)

Table 5. Major Players of Cytokine

Table 6. Global PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)

Table 7. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

Table 8. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2017-2022) & ($ million)

Table 9. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)

Table 10. Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022) & (US$/Kg)

Table 11. Global PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)

Table 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Table 13. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2017-2022)

Table 14. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2017-2022)

Table 15. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022) & (US$/Kg)

Table 16. Global PD-1 and PD-L1 Inhibitors Sales by Company (2020-2022) & (Tons)

Table 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)

Table 18. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022) ($ Millions)

Table 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)

Table 20. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2020-2022) & (US$/Kg)

Table 21. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area

Table 22. Players PD-1 and PD-L1 Inhibitors Products Offered

Table 23. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2017-2022) & (Tons)

Table 27. Global PD-1 and PD-L1 Inhibitors Sales Market Share Geographic Region (2017-2022)

Table 28. Global PD-1 and PD-L1 Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global PD-1 and PD-L1 Inhibitors Sales by Country/Region (2017-2022) & (Tons)

Table 31. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2017-2022)

Table 32. Global PD-1 and PD-L1 Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)

Table 35. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)

Table 36. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)

Table 38. Americas PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)

Table 39. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

Table 40. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)

Table 41. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Table 42. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022) & (Tons)

Table 43. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)

Table 44. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2017-2022)

Table 46. APAC PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)

Table 47. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

Table 48. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)

Table 49. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Table 50. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)

Table 51. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)

Table 52. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)

Table 54. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)

Table 55. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

Table 56. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)

Table 57. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (Tons)

Table 59. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (Tons)

Table 63. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (Tons)

Table 65. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Inhibitors

Table 67. Key Market Challenges & Risks of PD-1 and PD-L1 Inhibitors

Table 68. Key Industry Trends of PD-1 and PD-L1 Inhibitors

Table 69. PD-1 and PD-L1 Inhibitors Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. PD-1 and PD-L1 Inhibitors Distributors List

Table 72. PD-1 and PD-L1 Inhibitors Customer List

Table 73. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (Tons)

Table 74. Global PD-1 and PD-L1 Inhibitors Sales Market Forecast by Region

Table 75. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)

Table 78. Americas PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (Tons)

Table 80. APAC PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)

Table 82. Europe PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (Tons)

Table 84. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2023-2028) & (Tons)

Table 86. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2023-2028)

Table 87. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2023-2028) & (Tons)

Table 90. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2023-2028)

Table 91. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck PD-1 and PD-L1 Inhibitors Product Offered

Table 95. Merck PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 96. Merck Main Business

Table 97. Merck Latest Developments

Table 98. Novartis Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 99. Novartis PD-1 and PD-L1 Inhibitors Product Offered

Table 100. Novartis PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 101. Novartis Main Business

Table 102. Novartis Latest Developments

Table 103. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 104. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered

Table 105. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 106. Bristol-Myers Squibb Main Business

Table 107. Bristol-Myers Squibb Latest Developments

Table 108. GlaxoSmithKline Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 109. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Product Offered

Table 110. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 111. GlaxoSmithKline Main Business

Table 112. GlaxoSmithKline Latest Developments

Table 113. Regeneron Pharmaceuticals Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 114. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product Offered

Table 115. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 116. Regeneron Pharmaceuticals Main Business

Table 117. Regeneron Pharmaceuticals Latest Developments

Table 118. Eli Lilly and Company Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 119. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Product Offered

Table 120. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 121. Eli Lilly and Company Main Business

Table 122. Eli Lilly and Company Latest Developments

Table 123. Roche Genetech Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 124. Roche Genetech PD-1 and PD-L1 Inhibitors Product Offered

Table 125. Roche Genetech PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 126. Roche Genetech Main Business

Table 127. Roche Genetech Latest Developments

Table 128. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 129. AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered

Table 130. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 131. AstraZeneca Main Business

Table 132. AstraZeneca Latest Developments

Table 133. Jiangsu HengRui Medicine Co., Ltd. Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 134. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Product Offered

Table 135. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 136. Jiangsu HengRui Medicine Co., Ltd. Main Business

Table 137. Jiangsu HengRui Medicine Co., Ltd. Latest Developments

Table 138. Curis Inc. Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 139. Curis Inc. PD-1 and PD-L1 Inhibitors Product Offered

Table 140. Curis Inc. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 141. Curis Inc. Main Business

Table 142. Curis Inc. Latest Developments

Table 143. Aurigene Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 144. Aurigene PD-1 and PD-L1 Inhibitors Product Offered

Table 145. Aurigene PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 146. Aurigene Main Business

Table 147. Aurigene Latest Developments

List of Figures

Figure 1. Picture of PD-1 and PD-L1 Inhibitors

Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2017-2028 (Tons)

Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. PD-1 and PD-L1 Inhibitors Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Humanized IgG1(Immunoglobulin 1)

Figure 10. Product Picture of Humanized IgG4(Immunoglobulin 5)

Figure 11. Product Picture of Cytokine

Figure 12. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2021

Figure 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)

Figure 14. PD-1 and PD-L1 Inhibitors Consumed in Oral

Figure 15. Global PD-1 and PD-L1 Inhibitors Market: Oral (2017-2022) & (Tons)

Figure 16. PD-1 and PD-L1 Inhibitors Consumed in Subcutaneous Injection

Figure 17. Global PD-1 and PD-L1 Inhibitors Market: Subcutaneous Injection (2017-2022) & (Tons)

Figure 18. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)

Figure 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2021

Figure 20. PD-1 and PD-L1 Inhibitors Revenue Market by Company in 2021 ($ Million)

Figure 21. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2021

Figure 22. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region in 2021

Figure 24. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)

Figure 25. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region in 2021

Figure 26. Americas PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)

Figure 27. Americas PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 28. APAC PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)

Figure 29. APAC PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 30. Europe PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)

Figure 31. Europe PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2017-2022 (Tons)

Figure 33. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)

Figure 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021

Figure 35. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021

Figure 36. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2021

Figure 41. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2021

Figure 42. China PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 46. India PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021

Figure 49. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021

Figure 50. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 51. France PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021

Figure 56. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021

Figure 57. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2021

Figure 63. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors

Figure 64. Industry Chain Structure of PD-1 and PD-L1 Inhibitors

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles